Affiliation:
1. Peking University Institute of Cardiovascular Sciences, Peking University Health Science Center; Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, 38 Xueyuan Road, Beijing 100191, China
Abstract
:
Cardiovascular diseases and fatty liver disease have become the leading causes of death in
modern society. However, the currently existing drugs do not solve all issues related to these diseases;
thus, it is expected that more potential drugs for clinical use will be developed. Undeniably, natural
products have attracted increasing attention. It is of great significance to identify effective active
monomer components for drug discovery and disease prevention. As a pure natural product, Agathis
dammara (AD) has antioxidant, hypolipidemic, hypoglycemic, antitumor, and anti-inflammatory activities.
However, at present, there are few reports regarding the effects of AD on chronic inflammatory
cardiovascular diseases, such as aneurysm, atherosclerosis, myocardial ischemia-reperfusion injury,
and cardiac hypertrophy and liver diseases such as fatty liver disease. AD and products derived from it
have a very broad application prospect for cardiovascular diseases and fatty liver disease.
Funder
National Natural Science Foundation of China
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology,General Medicine
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献